Table 1 Patient’s clinical characteristics and outcomes of the intervention of all patients admitted to HaH

Demographics & baseline use of resources

 Age, mean (sd)^a

73.11 (16.73)

 Gender; n (%)^a

  Male

15,214 (47.69)

  Female

16,687 (52.31)

 AMG, mean (sd)^a

29.51 (16.48)

 AMG category, n (%)

  Very low risk < P₅₀

266 (0.83)

  Low risk [P₅₀-P₈₀)

1,769 (5.55)

  Moderate risk [P₈₀-P₉₅)

4,723 (14.81)

  High risk [P₉₅-P₉₉)

5,476 (17.17)

  Very high risk ≥ P₉₉

19,667 (61.64)

 Patients with HRSN associated to housing and economic conditions, n (%)^a

5,063 (15.86)

 Patients with HRSN associated to family and social environment, n (%)^a

9,903 (31.03)

 Patients receiving palliative care, n (%)

1,437 (4.5)

 Patients requiring hospital admissions within the 12 months before the admission, n (%)^a

15,957 (50.16)

 Patients requiring emergency room visits within the 12 months before the admission, n (%)^a

25,812 (81.14)

 Total Expenditure in € within the 12 months before the admission, median (P₂₅-P₇₅)^a

4,153.4 (1,695.8 - 8424.6)

Hospitalization episode

 LoS, mean (sd)

8.47 (6.34)

 Patients requiring in-hospital all-cause readmissions, n (%)

1,706 (5.35)

 Patients requiring emergency room visits without in-hospital readmission, n (%)

1,339 (4.20)

 Mortality, n (%)

103 (0.32)

 Queralt Index, mean (sd)

28.34 (16.24)

 Case Mix Index

0.66

Health outcomes 30 days after discharge

 Mortality, n (%)

1,383 (4.35)

 Patients requiring hospital admissions, n (%)

3,327 (10.42)

 Patients requiring emergency room visits, n (%)

6,136 (19.29)

 Total Expenditure in €, median (P₂₅-P₇₅)

279.1 (119.3 - 758.7)